Monitoring α-synuclein aggregation-Reference-Cited by-同舟云学术

Monitoring α-synuclein aggregation

Published:2023-01 Issue: Volume:176 Page:105966
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Estaun-Panzano Juan,Arotcarena Marie-Laure,Bezard Erwan

Funder

Horizon 2020

European Research Council

Publisher

Elsevier BV

Subject

Neurology

Reference223 articles.

1. α-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities;Alam;J. Neurochem.,2019

2. In situ proximity ligation assay reveals co-localization of alpha-synuclein and SNARE proteins in murine primary neurons;Almandoz-Gil;Front. Neurol.,2018

3. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. bioRxiv;Altay,2022

4. The association between α-synuclein and α-tubulin in brain synapses;Amadeo;Int. J. Mol. Sci.,2021

5. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients;Araki;Sci. Rep.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanobiosensor engineering in the diagnosis of neurodegenerative disorders;Results in Engineering;2024-12

2. Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers;Bulletin of Experimental Biology and Medicine;2024-09-11

3. Research advancement in fluid biomarkers for Parkinson’s disease;Expert Review of Molecular Diagnostics;2024-09-11

4. Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson’s disease;Molecular Diversity;2024-08-15

5. MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity;2024-07-08